PAPER
Highly Alkyl Substituted Dicatechol Ligand
2237
3,4,5-Tris(hexadecyloxy)benzene (2)
IR (KBr): 3413, 3335, 3206, 2918, 2850, 1597, 1505, 1467, 1395,
1241, 1115, 814, 721 cm–1.
1,2,3-Trihydroxybenzene (1; 1.00 g, 7.94 mmol), K2CO3 (5.24 g,
37.7 mmol) and 1-bromo hexadecane (8.00 g, 26.2 mmol) were dis-
solved in DMF (50 mL). The mixture was stirred at 80 °C for 6 h
and then additional 1-bromohexadecane (2.70 g, 8.74 mmol) was
added. After heating overnight and cooling to r.t., the mixture was
poured onto ice. The precipitate was isolated by filtration and re-
crystallized from acetone; yield: 5.4 g (86%); white solid, mp
70 °C.
1H NMR (CDCl3): = 6.90 (t, J = 8.3 Hz, 1 H), 6.53 (d, J = 8.3 Hz,
2 H), 3.96 (t, J = 6.5 Hz, 4 H), 3.94 (t, J = 6.7 Hz, 2 H), 1.83 (m, 6
H), 1.50 (m, 6 H), 1.25 (m, 72 H), 0.88 (t, J = 6.7 Hz, 9 H).
13C NMR (CDCl3): = 153.5 (C), 138.5 (C), 123.1 (CH), 106.8
(CH), 73.4 (CH2), 69.1 (CH2), 64.0 (CH2), 51.3 (CH2), 34.1 (CH2),
32.9 (CH2), 32.0 (CH2), 29.8 (CH2), 29.7 (CH2), 29.5 (CH2), 29.4
(CH2), 29.2 (CH2), 28.8 (CH2), 28.2 (CH2), 26.3 (CH2), 26.2 (CH2),
25.8 (CH2), 22.8 (CH2), 22.7 (CH2), 14.2 (CH3).
UV-Vis (MeOH): max = 191, 209, 270 nm.
MS (EI, 70 eV): m/z = 814 ([M]+, 100%).
HRMS (EI, 70 eV): m/z calcd for C54H103O3N: 813.7938. Found:
813.7985.
Anal. Calcd for C54H103O3N: C, 79.64; H, 12.75; N, 1.72. Found: C,
79.61; H, 12.21; N, 1.82.
7-{3-[(6-Carboxy-2,2-diphenyl-1,3-benzodioxol-4-yl)oxy]-
propoxy}-2,2-diphenyl-1,3-benzodioxole-5-carboxylic Acid (8)
KOH (2.55 g, 45.4mmol) was added to a solution of 77 (2.94 g, 4.00
mmol) in dioxane (70 mL) and EtOH (70 mL). The mixture was re-
fluxed for 2.5 h and the solvent was removed in vacuum. The resi-
due was dissolved in H2O and the pH was adjusted to 8 by adding
concd HCl. The resulting precipitate was isolated and washed with
H2O; yield: 2.83 g (quant.); white solid.
1H NMR (DMSO-d6): = 7.50 (m, 8 H), 7.39 (m, 12 H), 7.30 (d,
J = 1.4 Hz, 2 H), 7.20 (d, J = 1.4 Hz, 2 H), 4.33 (t, J = 6.3 Hz, 4 H),
2.20 (m, 2 H).
IR (KBr): 3370, 2916, 2849, 1604, 1471, 1296, 1259, 1224, 1119,
1106, 717 cm–1.
UV-Vis (CHCl3): max = 227, 369 nm.
MS (EI, 70 eV): m/z = 799 ([M]+, 100%).
13C NMR (DMSO-d6): = 166.5 (C), 147.6 (C), 141.9 (C), 139.1
(C), 129.5 (CH), 128.6 (CH), 125.8 (CH), 125.1 (C), 118.3 (C),
112.4 (CH), 103.8 (CH), 66.5 (CH2), 30.7 (CH2).
Anal. Calcd for C54H102O3 0.5CH2Cl2: C, 77.76; H, 12.88. Found:
C, 77.76; H, 11.88.
IR (KBr): 3436, 3064, 1684, 1630, 1507, 1436, 1325, 1273, 1208,
1118, 1044, 1019, 775, 762, 701 cm–1.
3,4,5-Tris(hexadecyloxy)nitrobenzene (3)
To a suspension of silica gel (2 g) in CH2Cl2 (20 mL) were added
first concd HNO3 (20 mL) and then a solution of tris(hexadecy-
loxy)benzene (2; 4.00 g, 5.01 mmol) in CH2Cl2 (30 mL). The mix-
ture was stirred for 15 min and the silica gel was removed by
filtration. The organic phase was washed with H2O and the product
was precipitated by addition of MeOH; yield: 3.64 g (86%); white
solid; mp 70 °C.
UV-Vis (MeOH): max = 270 nm.
Anal. Calcd for C43H32O10: C, 72.87; H, 4.45. Found: C, 72.27; H,
4.67.
7-{3-[(2,2-Diphenyl-6-{[3,4,5-tris(hexadecyloxyanilino]-car-
bonyl}-1,3-benzodioxol-4-yl)oxy]propoxy}-2,2-diphenyl-N-
[3,4,5-tris(hexadecyloxy)phenyl]-1,3-benzodioxole-5-carboxylic
Acid (9)
1H NMR (CDCl3): = 7.47 (s, 2 H), 4.05 (m, 6 H), 1.84 (m, 4 H),
1.75 (m, 2 H), 1.48 (m, 6 H), 1.26 (br, 72 H), 0.88 (t, J = 6.9 Hz, 9
To a solution of 3,4,5-tris(hexadecyloxy)aniline (4; 452 mg, 0.56
mmol) and 8 (197 mg, 0.28 mmol) in pyridine (20 mL) was added
triphenyl phosphite (146 L, 0.56 mmol). After refluxing for 48 h,
the mixture was allowed to cool to r.t. and the crude product was
precipitated by the addition of EtOH. Purification was done by
chromatography (silica gel, CH2Cl2); yield: 175 mg (28%); white
solid; mp 91 °C.
1H NMR (CDCl3): = 7.61 (s, 2 H), 7.55 (m, 8 H), 7.33 (m, 12 H),
7.14 (d, J = 1.5 Hz, 2 H), 7.00 (d, J = 1.5 Hz, 2 H), 6.84 (s, 4 H),
4.39 (t, J = 6.0 Hz, 4 H), 3.91 (t, J = 6.5 Hz, 8 H), 3.90 (t, J = 6.6
Hz, 4 H), 2.28 (quin, J = 6.0 Hz, 2 H), 1.75 (m, 12 H), 1.44 (m, 12
H), 1.27 (m, 144 H), 0.88 (t, J = 7.0 Hz, 18 H).
13C NMR (CDCl3): = 164.8 (C), 153.2 (C), 148.8 (C), 142.6 (C),
139.5 (C), 138.4 (C), 135.0 (C), 133.5 (C), 129.5 (C), 129.4 (C),
128.3 (C), 126.3 (CH), 118.5 (C), 110. 0 (CH), 101.2 (CH), 99.1
(CH), 73.5 (CH2), 69.1 (CH2), 66.4 (CH2), 60.4 (CH2), 32.0 (CH2),
30.4 (CH2), 29.8 (CH2), 29.7 (CH2), 29.5 (CH2), 29.4 (CH2), 26.2
(CH2), 26.1 (CH2), 22.7 (CH2), 14.1 (CH3).
H).
13C NMR (CDCl3): = 152.7 (C), 143.8 (C), 143.2 (C), 102.2 (CH),
73.8 (CH2), 69.5 (CH2), 32.0 (CH2), 30.3 (CH2), 29.7 (CH2), 29.6
(CH2), 29.5 (CH2), 29.4 (CH2), 29.1 (CH2), 26.0 (CH2), 22.7 (CH2),
14.1 (CH3).
IR (KBr): 3433, 2955, 2917, 2849, 1512, 1469, 1346, 1123, 720
cm–1.
UV-Vis (CHCl3): max = 227, 333 nm.
MS (EI, 70 eV): m/z = 844 ([M]+, 82 %).
HRMS (EI, 70 eV): m/z Calcd for C54H101O5N: 843.7680. Found:
843.7642.
Anal. Calcd for C54H101O5N 0.5H2O: C, 76.00; H, 12.05; N: 1.64.
Found: C, 75.85; H, 11.64; N, 1.63.
3,4,5-Tris(hexadecyloxy)aniline (4)
A solution of 3 (1.03 g, 1.23 mmol) in CH2Cl2 (150 mL) was stirred
with PtO2 H2O (150 mg) under an atmosphere of H2. The reaction
was followed by TLC (CH2Cl2). After 36 h, the catalyst was filtered,
the solvent was removed in vacuum and the crude product was pu-
rified by recrystallization from acetone; yield: 711 mg (71%); white
solid; mp 54 °C.
1H NMR (CDCl3): = 6.03 (s, 2 H), 3.91 (t, J = 6.5 Hz, 4 H), 3.85
(t, J = 6,6 Hz, 2 H), 1.77 (m, 4 H), 1.71 (m, 2 H), 1.45 (m, 6 H), 1.26
(br, 72 H), 0.88 (t, J = 6.9 Hz, 9 H).
IR (KBr): 3305, 2919, 2851, 1604, 1504, 1468, 1433, 1326, 1209,
1119, 1046, 1021, 722, 699 cm–1.
UV-Vis (CHCl3): max = 222, 227, 296 nm.
Anal. Calcd for C151H234O14N2: C, 78.85; H, 10.18; N, 1.22. Found:
C, 78.53; H, 10.02; N, 1.02.
3-[3-(2,3-Dihydroxy-5-{[3,4,5-tris(hexadecyloxy)anilino]-car-
bonyl}phenoxy)propoxy]-4,5-dihydroxyy-N-[3,4,5-tris(hexa-
decyloxy)phenyl]benzamide (10-H4)
Compound 9 (175 mg, 0.08 mmol) was refluxed overnight in triflu-
oroacetic acid (20 mL). The solvent was removed in vacuum and the
13C NMR (CDCl3): = 153.8 (C), 139.5 (C), 132.3 (C), 95.6 (CH),
73.6 (CH2), 69.1 (CH2), 31.9 (CH2), 30.3 (CH2), 29.7 (CH2), 29.4
(CH2), 26.2 (CH2), 26.1 (CH2),. 22.7 (CH2), 14.1 (CH3).
Synthesis 2001, No. 15, 2234–2238 ISSN 0039-7881 © Thieme Stuttgart · New York